World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
GlaxoSmithKline Reduces Full-Year Earnings Forecast
Keywords:
Tags:
Bribery charges against Glaxo in China- 2013-2014
07/15/2013
Grouped Articles
Wall Street Journal 07/16/2013
Glaxo Used Travel Firms for Bribery, China Says
New York Times 07/15/2013
Glaxo Cites Possible Violations in China
Wall Street Journal 07/23/2013
Glaxo Names New China Chief Amid Bribery Probe
Wall Street Journal 07/26/2013
Wall Street Journal 10/24/2013
Glaxo Must Show It's Not Winded
Wall Street Journal 10/24/2013
Glaxo performance
07/02/2012
Grouped Articles
Glaxo Must Show It's Not Winded
Wall Street Journal 10/24/2013
GlaxoSmithKline Reduces Full-Year Earnings Forecast
Wall Street Journal 07/24/2014
Glaxo Posts Sharp Fall in Profit
Wall Street Journal 02/05/2015
Glaxo in $3 Billion Settlement
Wall Street Journal 07/02/2012
GSK Earnings Slide as Europe, U.S. Fall
Wall Street Journal 11/01/2012
Glaxo Plans More Restructuring as Profit Sinks
Wall Street Journal 02/07/2013
John Bussey on how China's actions against Glaxo form part of the effort to cut drug prices and reduce healthcare costs
07/25/2013
Bussey points out that cutting drug prices is part of the effort to help consumers and reform the economy of the new leadership of Jinping-Keqiang in China. Consumer spending has dropped in the last decade to 35% of GDP and this is needed for rebalancing the economy, as ordinary Chinese have to set aside a large portion of savings for costly drugs and healthcare.
Grouped Articles
Politics Is a Bitter Pill for Glaxo
Wall Street Journal 07/25/2013
Wall Street Journal 10/24/2013
Glaxo Must Show It's Not Winded
Wall Street Journal 10/24/2013
GlaxoSmithKline Reduces Full-Year Earnings Forecast
Wall Street Journal 07/24/2014
GlaxoSmithKline Found Guilty of Bribery in China
Wall Street Journal 09/20/2014
Mylan Reacts to EpiPen Backlash
WSJ 08/26/2016
Glaxo strategies
02/07/2013
Grouped Articles
Glaxo Must Show It's Not Winded
Wall Street Journal 10/24/2013
Wall Street Journal 04/23/2014
Deal Flurry Shows Drug Makers' Swing Toward Specialization
Wall Street Journal 04/23/2014
GlaxoSmithKline Reduces Full-Year Earnings Forecast
Wall Street Journal 07/24/2014
Glaxo Posts Sharp Fall in Profit
Wall Street Journal 02/05/2015
Glaxo Plans More Restructuring as Profit Sinks
Wall Street Journal 02/07/2013
Glaxo in the pharmaceutical market in China
04/15/2010
Grouped Articles
GlaxoSmithKline Probes Bribe Allegations in China
Wall Street Journal 06/12/2013
Wall Street Journal 07/16/2013
Glaxo Cites Possible Violations in China
Wall Street Journal 07/23/2013
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Glaxo Names New China Chief Amid Bribery Probe
Wall Street Journal 07/26/2013
Wall Street Journal 10/24/2013
Glaxo restructuring.
06/12/2008
Grouped Articles
GlaxoSmithKline Reduces Full-Year Earnings Forecast
Wall Street Journal 07/24/2014
Glaxo Is Eliminating R&D Jobs As Part of Cost-Cutting Plan
Wall Street Journal 06/12/2008
Glaxo Gives Actelion Sweet Deal for Drug
Wall Street Journal 07/15/2008
Glaxo Aims to Cut R&D Staff by 6%
Wall Street Journal 09/30/2008
Glaxo Plans 12% Reduction in Its U.S. Drug Sales Force
Wall Street Journal 11/06/2008
Glaxo Plans More Restructuring as Profit Sinks
Wall Street Journal 02/07/2013
Glaxo China
04/15/2010
Grouped Articles
GlaxoSmithKline Probes Bribe Allegations in China
Wall Street Journal 06/12/2013
GlaxoSmithKline Accused of Corruption by China
New York Times 07/11/2013
Wall Street Journal 07/16/2013
Glaxo Cites Possible Violations in China
Wall Street Journal 07/23/2013
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Glaxo Names New China Chief Amid Bribery Probe
Wall Street Journal 07/26/2013
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us